Levels of oxidative metabolites, antioxidants and neopterin in Nigerian pulmonary tuberculosis patients.

Year 2011, Volume: 8 Issue: 3, 214 - 217, 01.09.2011

Moses Olayemi Akiibinu Ebenezer Olugbenga Ogunyemi Emmanuel Olusegun Shoyebo

https://izlik.org/JA58FU67CA

Abstract

Keywords

-

Levels of oxidative metabolites, antioxidants and neopterin in Nigerian pulmonary tuberculosis patients.

https://izlik.org/JA58FU67CA

Abstract

-

Keywords

-

References

• Houben E, Nguyen L, Pieters J. "Interaction of pathogenic mycobacteria with the host immune system". Curr Opin Microbiology 2006;9(1):76–85.
• Singh R, Manjunatha U, Helena I, Bushoff M, Hwan-Ha Y. PA-824 kills non replicating M. tuberculosis by intracel- lular NO release. Science 2008;322(5906);1392-5.
• Nathan C. Inducible nitric oxide synthase: what differ- ence does it make? Journal of Clinical Investigation 1997; 100:2417-23.
• Ramanujam M.D. Free radicals and antioxidants–current status. www.meclindia.net/article/anitoxidantsasp; 2004
• Plit Ml, Theron AS, Fickl H, Van Rensburg CE, Pendel S, Anderson R. Influence of antimicrobial chemotherapy and smoking status on the plasma concentration of vitamin C; Vitamin E, beta-carotene, acute phase reactants, iron and lipid peroxides in patients with pulmonary tuberculo- sis. Intern J Tuberc lung Dis 1998;2(7):590-6.
• Chandara I, Lalitha VK, Silambu C, et al. Serum neop- terin levels in HIV–infected patients with and without tu- berculosis. Indian J Med Research 2005;121:220-5.
• Turgut T, Akbulut H, Devesi F, Kacar C, Muz MH. Serum interleukin-2- and neopterin levels as useful markers for treatment of active pulmonary tuberculosis. Tohoku J Experimental Med 2006;209(4):321-8
• Miyazawa T. Determination of phopholipid hydroperox- ides in human blood plasma by a chemiluminescence HPLC assay. Free Radical Biol Med 1989;7:209-17.
• Varshney R, Kale RK. Effect of calmodulin antagonist on radiation-induced lipid peroxidation in microsomes. Int J Rad Boil 1990;58:733-43.
• Wanchu A, Khullar M, Bhatnagar A, Sud A, Bambery P, Singh S. Pentoxiphylline Reduces Nitric Oxide Production among Patients with HIV Infection. Immunol Lett 2000; 74:121–5.
• Smith D. Zouridakis E. Mariani M. Fredericks S. Cole D. Kaski J. Neopterin levels in patients with coronary artery disease are independent of Chlamydia pneumoniae sero- positivity. Am Heart J 2003;146(1): 69-74.
• Harma M, Harma M. Erel O. Oxidative stress in women with pre-eclampsia Am J Obstest Gynaecol 2005;192: 656-7.
• Benzie IE, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power (the FRAP as- say). Ann Biochem 1996;239:70-6.
• Suttle NF. The Veterinary Record 1986; 519-22.
• Beutler E, Dunn O and Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963;65:882-8.
• Sinha KA. Colorimetry assay of catalase. Analytical Biochemistry 1972;47:389-94.
• Nwanjo H. U. Free Radicals Scavenging Potential of the aqueous extract of Viscum Album (Mistletoe) leaves in diabetic wistar rats hepatocytes. The Internet Journal of Nutrition and Wellness. 2007; (3) 2.
• Wiid I. Seaman T. Hoal Eg. Benade AJ. Van Helden PD. Total antioxidant levels are low during active TB and rise with anti-tuberculosis therapy. IUBMB Life 2004;56(2): 101-6.
• Akiibinu MO, Arinola OG, Ogunyemi EO. Plasma neopterin and peroxide levels in pulmonary tuberculosis patients on chemotherapy with or without micronutrient supplemen- tation. Pakistan J Med Sci 2009;25(3):380-5.
• Kwiatsowska S. Piasecka G. Zieba M. Piotrowski W. Nowak D. Increased serum concentrations of conjugated diens and malondialdehyde in patients with pulmonary tuber- culosis. Respir Med 1999;93(4):272-6.
• deRojas-Walker T, Tamir SJ, H Wishnock J, Tennaaum SR. Nitric oxide inducxes oxidative damage in addition to de- amination in macrophage DNA. Chem Research Toxicol 1995;8:473-7.
• Apple FS, Wu AH, Mair J, et al. Future Biomarkers for de- tection of Ischemia and risk stractification in acute coro- nary syndrome. Clin Chemistry 2005;51:810-24.
• Akiibinu MO, Arinola OG, Ogunlewe JO, Onih EA. Non enzymatic antioxidants and Nutritional profile in newly diagnosed pulmonary tuberculosis patients in Nigeria. African J Biomed Research 2007;10:223-8.
• Madebo T, Lindtjİrn B, Aukrust P, Rolf K Berge. Circulating antioxidants and lipid peroxidation products in untreated tuberculosis patients in Ethiopia. Am J Clin Nutrition. 2003;78(1):117-22.
• Arinola OG, Akiibinu MO. Influence of Mycobacterium tu- berculosis infection on the serum levels of antioxidant vitamins and trace elements. The tropical Journal of Health Sciences 2008;15(2):1-4.
• Sasaki Y, Yamagishi F, Yagi T, Mizutani F, A case of pul- monary tuberculosis with pan-cytopenia accompanied to bone marrow gelatinous transformation. Kekkaku 1999; 74 (4):361-4.
• Aily D.C., Camargo S.S., Paro H.S., et al. Systematic my- cobacteriosis in AIDS patients as determined by blood cultures on biphasic medium. Rev Argent Microbiol 1999; 31:53-7.
• Schon T, Gebre N, Sundqvist T, Aderaye G, Britton S. Effects of HIV co-infection and chemotherapy on the uri- nary levels of nitric oxide metabolites in patients with pulmonary tuberculosis. Scand J Infect Dis 1999; 31:123–6.
• Gaston B, Drazen JM, Loscalzo J, and Stanler JS. The bi- ology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994;149:538-51.
• Kaufmann S. "Protection against tuberculosis: cytokines, T cells, and macrophages". Ann Rheum Dis 2002;61:Suppl 2:ii54-8.
• Joshi AS, Li XC, Nimrod AC, ElSohly HN, Walker LA, Clark AM. Dihydrochalcones from Piper longicaudatum. Planta Medica 2001;67:186–8.
• Hogg N, Kalyanaraman B, Joseph J, Struck A, Parthasarthy S. Inhibition of low-density lipoprotein oxidation by nitric oxide. FEBS Letters 1993;334:170-4.
• Beckman JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR. Extensive nitration of protein ty- rosine in human atheroscerosis detected by immunohisto- chemistry. Biological Chemistry; Hoppe Seyler 1994;375: 81-8.
• Ferdinandy P, Schulz R. Nitric oxide, superoxide, and per- oxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. British J Pharmacol 2003;138:532–43.